Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Correlation of fecal metabolomics and gut microbiota in mice with endometriosis

In a mouse model of endometriosis, gut microbiota diversity and abundance fell, and fecal metabolites shifted in step. Chenodeoxycholic and ursodeoxycholic acids rose while alpha-linolenic acid and 12,13-EOTrE dropped, implicating altered bile acid and alpha-linolenic acid metabolism as candidate markers of the disease.

2026-07-05

Insights into the gut microbiome of vitiligo patients from India

In an Indian cohort, vitiligo patients showed gut dysbiosis with a lower Firmicutes to Bacteroidetes ratio, depletion of butyrate-producing bacteria, and more mucin-degrading genes, and a cross-cohort classifier separated patients from controls with about 82 percent accuracy.